I’m pleased to announce that the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for early stage investigators (ESIs) will be reissued in the spring of 2023. MIRA provides support for a research program in an ESI’s laboratory that falls within the NIGMS mission. For details, see NOT-GM-23-017.
The reissued FOA will essentially be the same as the previous one, with a couple of minor changes:
Continue reading “Intent to Reissue MIRA Funding Opportunity Announcement for Early Stage Investigators (R35)”
UPDATE: The slides [PDF] and video from this webinar are now available.
I’m pleased to announce that the Maximizing Investigators’ Research Award (MIRA) funding opportunity announcement (FOA) for established and new investigators (PAR-22-180) has been reissued. MIRA provides support for the program of research in an investigator’s laboratory that falls within the NIGMS mission. The next application due date is January 17, 2023.
We’re hosting a webinar to discuss the key features of this FOA and to answer your questions:
Friday, October 21, 12:30-2:00 p.m. ET
Continue reading “Webinar for the NIGMS Maximizing Investigators’ Research Award (MIRA) Program”
Zoom meeting link
Meeting ID: 160 903 8368
In this Feedback Loop post, we revisit our previous analysis of application, review, funding, and demographic trends for the Maximizing Investigators’ Research Award (MIRA) program over Fiscal Years (FYs) 2019 to 2021. We look at trends for applicants by race/ethnicity and by gender. Due to privacy requirements and small numbers, applicants from underrepresented racial and ethnic groups in biomedical research (Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian and other Pacific Islander) are combined into a larger group that can be reported. Because of the small applicant numbers, we’re unable to show intersectional analyses of race/ethnicity and gender or analyses of applicants with disabilities.
Table 1 shows the number of new awards made and associated award rates by fiscal year for Established Investigators (EIs) and Early Stage Investigators (ESIs).
Continue reading “Application, Review, Funding, and Demographic Trends for Maximizing Investigators’ Research Awards (MIRA): FYs 2019-2021”
We’ve issued a funding opportunity announcement (FOA) (PAR 22-180) to provide sustained support for biomedical research through our Maximizing Investigators’ Research Award (MIRA) program. This FOA allows applications from eligible NIGMS-funded investigators and from New Investigators proposing research within the scientific mission of NIGMS. The FOA also allows renewal applications from all eligible MIRA grantees (established and ex-Early Stage Investigators). Program directors (PDs)/principal investigators (PIs) who are currently Early Stage Investigators (ESIs) should apply through the ESI MIRA FOA and not to this announcement.
Continue reading “NIGMS Continues and Expands Its MIRA Program”
UPDATE: The video and slides [PDF] from the MIRA webinar are now available.
We recently reissued the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (PAR-20-117). The first application due date is October 2, 2020.
We’re hosting a webinar to discuss this FOA and to answer your questions about the program on Thursday, August 6, 1:00-2:30 p.m. ET. To access the webinar, visit the WebEx meeting page (link no longer available). We plan to post the archived webinar and slides on the MIRA webpage after the event.
Continue reading “Webinar and Other Resources for New MIRA ESI Funding Opportunity”
One of the most common questions we receive about the Maximizing Investigators’ Research Award (MIRA) program is the likelihood of an application’s funding given a certain overall impact score.
Frequent readers of this blog may note that we typically provide statistics as they relate to our R01 portfolio, but we’ve yet to provide a similar “funding curve” for the MIRA program. One reason that MIRA applications haven’t been included in these analyses is that, unlike most R01 applications, MIRA R35 applications don’t receive a percentile score. The percentile score allows for normalization of overall impact scores across study sections to account for any differences in scoring behavior that are observed in review panels. See the Office of Extramural Research’s comprehensive blog post for more information about overall impact scores and percentiles.
Continue reading “Funding Trends: MIRA Applications and Overall Impact Scores”